in this issue
Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients
Swiss health-care group Galenica to split into two listed companies
9:33 AM MDT | August 12, 2014 | Natasha Alperowicz
Galenica (Bern, Switzerland) said today that it is adapting a new management structure. The group will be headed by two CEOs, one in charge of Vifor Pharma, formerly the pharma division, and one of Gelenica Santé, the former Santé division. Both CEOs will report directly to the executive chairman. The role of CEO Galenica Group is being abolished. With this move, the board is creating the best conditions for both the Vifor Pharma and Galenica Santé units to prepare to become listed, independent companies when the time is right, the company...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee